QVIDTVM Management LLC 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
QVIDTVM Management LLC disclosed 8 US equity positions worth $142.9m in its Q3 2024 13F filing. The largest position was BIO at 29.5% of the reported book, followed by SOLV and WAB.
What did QVIDTVM Management LLC own in Q3 2024? Top 8 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | BIO BIO RAD LABS INC | Healthcare | 29.5% | $42.1m | 125,938 | – | |
| 2 | SOLV SOLVENTUM CORP | Healthcare | 24.3% | $34.7m | 497,276 | – | |
| 3 | WAB WABTEC | Industrials | 13.8% | $19.7m | 108,475 | – | |
| 4 | RTO RENTOKIL INITIAL PLC | 13.1% | $18.7m | 750,176 | – | ||
| 5 | XRAY DENTSPLY SIRONA INC | Healthcare | 8.7% | $12.4m | 458,866 | – | |
| 6 | BRCC BRC INC | 7.7% | $11.0m | 3,219,929 | – | ||
| 7 | ZGN ERMENEGILDO ZEGNA N V ORD SHS | Consumer Cyclical | 2.0% | $2.9m | 295,562 | – | |
| 8 | SINGULAR GENOMICS SYSTEMS INC | 0.9% | $1.3m | 83,558 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.